4-aminopyridine is not just a symptomatic therapy, it has a neuroprotective effect – Yes

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Access to Document

@article{f15d5bc7d1e94ae485ba42414d684470,

title = "4-aminopyridine is not just a symptomatic therapy, it has a neuroprotective effect – Yes",

author = "Strijbis, {Eva M.M.} and {Nij Bijvank}, {Jenny A.} and Joep Killestein",

year = "2020",

month = oct,

day = "1",

doi = "10.1177/1352458520923951",

language = "English",

volume = "26",

pages = "1309--1310",

journal = "Multiple Sclerosis",

issn = "1352-4585",

publisher = "SAGE Publications Ltd",

number = "11",

}

TY - JOUR

T1 - 4-aminopyridine is not just a symptomatic therapy, it has a neuroprotective effect – Yes

AU - Strijbis, Eva M.M.

AU - Nij Bijvank, Jenny A.

AU - Killestein, Joep

PY - 2020/10/1

Y1 - 2020/10/1

UR - http://www.scopus.com/inward/record.url?scp=85087551685&partnerID=8YFLogxK

U2 - 10.1177/1352458520923951

DO - 10.1177/1352458520923951

M3 - Article

C2 - 32628062

AN - SCOPUS:85087551685

VL - 26

SP - 1309

EP - 1310

JO - Multiple Sclerosis

JF - Multiple Sclerosis

SN - 1352-4585

IS - 11

ER -